Live donation benefits recipients, but the long-term consequences for donors remain uncertain. Renal and Lung Living Donors Evaluation Study surveyed kidney donors (N ¼ 2455; 61% women; mean age 58, aged 24-94; mean time from donation 17 years, range 5-48 years) using the Short Form-36 Health Survey (SF-36). The 95% confidence intervals for White and AfricanAmerican donors included or exceeded SF-36 norms. Over 80% of donors reported average or above average health for their age and sex (p < 0.0001). Donors' agesex adjusted physical component summary (PCS) scores declined by half a point each decade after donation (p ¼ 0.0027); there was no decline in mental component summary (MCS) scores. White donors' PCS scores were three points higher (p ¼ 0.0004) than nonWhites'; this difference remained constant over time. Nine percent of donors had impaired health (PCS or MCS score >1 SD below norm). Obesity, history of psychiatric difficulties and non-White race were risk factors for impaired physical health; history of psychiatric difficulties was a risk factor for impaired mental health. Education, older donation age and a firstdegree relation to the recipient were protective factors. One percent reported that donation affected their health very negatively. Enhanced predonation evaluation and counseling may be warranted, along with ongoing monitoring for overweight donors.
Introduction
The benefits of living kidney donation to the recipient are well-established (1-2), but uncertainty remains regarding the long-term impacts on living donors (3) . Studies have confirmed that surgical complication rates are low, and serious psychiatric sequelae are rare (4) (5) (6) . Reports suggest that the majority of living donors experience levels of health-related quality of life (HRQOL) similar to or exceeding that of the general population (7) (8) (9) . Nevertheless, it has been consistently shown that some donors (<5%) experience significant psychological distress or retain highly negative attitudes about donation (10, 11) . Information on the predictors and correlates of poor HRQOL outcomes is extremely limited (5) , particularly for minority donors or the growing number of overweight donors (3, 6, (12) (13) (14) .
The Renal and Lung Living Donors Evaluation Study (RELIVE) provided a unique opportunity to investigate the long-term HRQOL of living donors. RELIVE conducted an extensive chart review to identify all living donor surgeries performed from 1963 to 2005 at three large US transplant centers (15) . Where possible, donor current address and phone contact information were derived from these records, and surviving donors requested to complete HRQOL questionnaires. The Short Form-36 Health Survey (SF-36) health survey (16) was included in this questionnaire because it is a standardized instrument with norms for US adults overall and grouped by age and sex. SF-36 results from the African-American Health Project (AAHP) (17) provided nondonor comparison data for African-American donors. The study objectives were to provide a comprehensive analysis of the HRQOL of a large and representative sample of living kidney donors, and to identify predictors of poor long-term HRQOL outcomes. We hypothesized that donors' current HRQOL would be influenced by factors known at the time of donation, and also influenced by perceptions regarding the donation experience such as expected recovery time, time to resumption of usual activities and comfort with decision to donate, among other factors.
Methods
The RELIVE study was designed to evaluate the medical and HRQOL outcomes of living kidney donors at three large US transplant centers. Details about RELIVE have been published elsewhere (15) .
Study design and population
An observational, cross-sectional survey of living kidney donors at least 5 years from time of donation was conducted. Enrollment is detailed in Figure 1 . Medical records from all living kidney donor surgeries conducted at the three study sites (N ¼ 8951) were reviewed. Surgeries performed after July 1, 2005 and known deaths were excluded, leaving 6909 potentially eligible donors (donation years 1963-2005) . A study invitation letter was sent to each donor. If no response was received, a follow-up letter and at least two telephone calls were made by study coordinators. Although a feebased Internet service was used to update address and phone numbers, current address and phone information could not be found for 13 .6% (n ¼ 938). Thirty-six percent overall (n ¼ 2501) did not respond to any study contact attempts. This varied by race: 34% of White donors, 58% of AfricanAmerican donors and 27% of donors of other or unknown race did not respond to any study contacts (Table S1 ). The true status of these donors is unknown; it is likely that some were passive refusals and others were never contacted. Fifty percent (n ¼ 3470) of the potentially eligible donors were contacted: 2455 consented and completed a study questionnaire; 931 refused consent; 79 consented but failed to return the questionnaire and five were unable to participate due to a language barrier. Among those contacted, rates of questionnaire completion were similar across transplant centers (67-76%) and for White and African-American donors (71% and 72%, respectively), and somewhat lower (65%) for donors of other or unknown race (Table S1) . Participation rates diminished with increasing time from donor surgery, from 79% for procedures done since January 2000 to 55% for those done in the 1960s.
This study was approved by the institutional review boards of the transplant (UAB: IRB approval number X070604010; UMN: IRB approval number 0905M66501; Mayo: IRB approval number 09-001345) and data coordinating centers (IRB approval number CR00032674 and protocol number HUM00004345). Informed consent was given by each participant.
Data collection
HRQOL questionnaires were mailed, self-administered and returned in postage-paid envelopes. Questionnaires included the SF-36, version 2 (16,18), a self-assessment of day-to-day function and well-being over the previous 4 weeks in eight domains of HRQOL. Domain scores are standardized to the age and sex distribution of the US adult population and combined to form physical and mental component summary (PCS and MCS) scores. Higher scores indicate better health. SF-36 results were compared to the National Health Measurement Survey (NHMS) (19) . Table S2 provides additional details about scoring and interpreting the SF-36.
Statistical analyses
Differences between respondents and nonrespondents by demographic characteristics, and differences among donors grouped by race, were examined using chi-square or Fisher's exact tests and one-way analyses of variance or rank tests for categorical and continuous predictors, respectively. Donors' SF-36 scores were compared to norms and other samples using ttests and rank tests. Quantile regression estimated the impact of race, procedure (laparoscopic or open) and time from donation on sex-by-age adjusted PCS and MCS scores. Multivariable logistic regression analyses identified factors that predicted a poor HRQOL outcome. Factors known prior to the time of donation surgery were used to fit an initial prediction model using a best subsets approach. Additional models tested whether donation experience variables were associated with poor HRQOL, after adjustment for the initial model. Missing data were imputed using IVEware (20) and analyses were conducted using SAS 9.2 (SAS Institute, Cary, NC). See the online supplement for statistical methodology details. A meaningful difference was defined as three points on the SF-36 MCS or PCS. Statistical significance was determined using a threshold of p < 0.01 to control Type I error and to focus on results where differences were most likely to be both statistically significant and clinically meaningful. Table S1 ).
Results

RELIVE donors (n
To investigate the representativeness of our sample, we compared the demographics of RELIVE donors to 2009 US kidney donors, using data published in the OPTN/SRTR 2010 Annual Report (see Table S3 ). Figure 2 . Donors reported significantly better function and well-being relative to the US adult population in all domains ( Table 2 , p < 0.0001 all). Overall physical and mental health were also higher (PCS scores, 51 AE 9, p < 0.0001; MCS scores, 53 AE 9, p < 0.0001). Compared to expected SF-36 profiles for people of their own sex and age, donors' scores were significantly higher (p < 0.0001, for all). Between 80% and 87% of donors' domain scores and 84% of their MCS and PCS values were in the average or above average range for their sex and age ( Table 2 ).
The HRQOL profiles of White and African-American donors are shown in Figure 3 . The 95% confidence intervals (CIs) for both White and African-American donors either included or exceeded US norms. White donors reported higher levels of social functioning than African-American donors (p ¼ 0.0007); there were no other differences. Norms for people aged 55-64 are five points lower (worse health) on the PCS (unadjusted) than norms for those aged 35-44, yet these donors (current mean age 58) reported higher PCS values than the younger US population (1998 US census population: 51% women, mean age 35 years).
Comparisons to other US populations Donor SF-36 scores are shown at the bottom of Figure 3 , along with results from the NHMS and the AAHP (17, 19) . Most NHMS profile scores are higher than the SF-36 norms. Despite this, donors' profiles compared favorably with NHMS results. Donors' PCS, MCS and scores on 7 of 8 (11) 58 (11) 52 (10) 53 (12) Years since donation 17 (10) 17 (10) 15 (8) 15 (8) BMI at donation 26 (5) 26 (5) 27 (5) 26 (4) (5) 116 (5) 9 (8) 5 (8) Spouse 219 (9) 208 (9) 8 (7) 3 (5) Friend 173 (7) 165 (7) 4 (4) 4 (7) Other unrelated 149 (6) 140 (6) 3 (3) 6 (10) domains were significantly higher or not different than NHMS results, and when the NHMS mental health score was higher, the difference was less than 1.2 points, below the SF-36 threshold for a clinically meaningful difference. HRQOL reports from African-American donors compared favorably to AAHP results, with donors reporting better general health perceptions (p < 0.0001), and no other differences.
Time from donation and HRQOL Sex-and age-adjusted PCS and MCS scores are depicted against time from donation in Figure 4 . In general, the most recent donors reported the highest PCS, while donors furthest away from donation reported the lowest scores. PCS declined by half a point with each decade after donation (slope [ poor (1%). Reports of fair or poor health are more common in the US population, 12.1% and 3.4%, respectively (19) . Figure 5 shows the proportions of RELIVE donors with excellent or very good self-rated health by race and education (used here as a surrogate for socioeconomic status), and comparable rates for US White and AfricanAmerican adults. After adjustment for education, White donors remained more likely to report excellent or very good health than either African-American donors (p ¼ 0.0034) or donors of other races (p ¼ 0.0004). Education was strongly correlated with self-rated health among US adults, White donors and donors of other or unknown race, but not among African-American donors.
Most donors reported that donation had no impact on their general health (73%). The remaining donors reported very positive (10%), somewhat positive (6%), somewhat negative (10%) or very negative (1%) impacts. Perceived impact of donation on health was related to race and to self-rated health (p < 0.0001, both). Donors of other or unknown race perceived a very negative health impact more often than White or African-American donors (6.8% vs. 0.8% and 2.7%, respectively). Despite perceiving a very negative impact of donation on their health, these donors rated their current health as reasonably good: excellent (4%), very good (8%), good (52%), fair (20%) or poor (12%), with missing data for one donor. In response to questions about their donation experience, about half (n ¼ 11 of 25) reported medical complications and/or emotional, psychological or substance abuse difficulties as a result of donation, and five reported that they never recovered from donor surgery. The others (14 of 25) did not report these problems; they resumed usual daily activities (e.g. driving, shopping for groceries) less than 3 months after donor surgery, and reported no medical complications or emotional, psychological or substance abuse difficulties as a result of donation. Predictors of impaired HRQOL Nine percent of donors (n ¼ 211) had significantly impaired physical HRQOL, scoring more than 10 points below their sex-by-age adjusted PCS norm (see Table S2 ). These individuals would typically be unable to do vigorous activity, have difficulty working and/or have pain or other chronic conditions. Nine percent of donors (n ¼ 233) had significantly impaired mental HRQOL based on the MCS. These individuals would typically have depressed or anxious moods some or most of the time, impacting their ability to socialize and function at work or home.
Predonation obesity, history of psychiatric difficulties and race were independent risk factors for impaired physical HRQOL, after adjustment for time since donation ( Table 3 ). After adjustment for the factors listed above, the following aspects of the donation experience were associated with increased risk of impaired physical HRQOL: estimated time to recover from surgery, longer than expected recovery time, longer time to resumption of usual activities, feeling depressed or ignored and medical or psychological difficulty after donation. With each increment of time to resumption of usual activities, the adjusted risk of impaired physical HRQOL increased threefold (OR ¼ 3.05). Perceptions of strong support from health providers, family and friends throughout the donation process were protective. Donors who reported positive impacts of donation on their health were also less likely to have impaired physical HRQOL.
History of psychiatric difficulties prior to donation more than tripled the risk of impaired mental HRQOL (OR ¼ 3.82), after adjustment for time (Table 3) . Being older at time of donation and having more education were protective. After adjustment for these predictors, increased risk of impaired mental HRQOL was associated with: time to recovery from surgery, time to resumption of usual activities, feeling depressed or ignored and medical or psychological difficulty after donation. Factors associated with reduced risk were positive perceptions of the donation experience, support from health providers, family and friends, comfort with decision to donate, positive impacts of donation on health and current education and marital status. Factors not associated with impaired HRQOL are listed in Table S4 .
Discussion
The kidney donors in the present study reported better physical and mental functioning and well-being than their counterparts in the general US population. With a larger sample and longer-term follow-up (average 17 years), these results confirm and extend earlier reports from single-center series (5, 8, 21) and recent international studies (7, 9) . Worldwide, about 27 000 living kidney donations are performed each year (22) . In Norway, Mjoen et al (9) surveyed 1414 donors who were on average 12.6 years from donation. These donors reported better HRQOL on all SF-36 domains compared to a population-based sample of adult Norwegians. An international collaborative (7) compared the HRQOL of nondonor controls to donors (N ¼ 203) who were on average 5.5 years from donation and found no differences in SF-36 scores.
This study presents new information on the outcomes of African-American kidney donors. African-American donors' SF-36 scores compared favorably to norms and results from a population-based sample of African-American adults (17) , and were generally similar to White donors' scores. After adjustment for age and sex, White donors had better overall physical functioning than non-White donors, but trends over time from donation did not differ by race, indicating that non-White donors did not have an accelerated decline in function or well-being in the decades following donation compared to White donors. These findings are reassuring, given evidence from administrative databases that AfricanAmerican and Hispanic donors have higher risks of developing hypertension, diabetes and chronic kidney disease after donation than White donors, although not higher rates than minority nondonors (23) .
It has been shown that differences in self-rated health are closely linked to socioeconomic status (24) , and therefore, we expected donors with greater educational attainments to rate their current health higher than those with less education. This was true for White donors, but not for African-American donors. Reasons for this are unknown, but we are mindful that the majority of the RELIVE AfricanAmerican donors hail from a single center and may differ from African-American donors elsewhere in ways we were unable to assess.
A novel finding from our work is the long-term HRQOL impact of excess body weight in otherwise healthy adults.
We did not have current BMI information, and could not determine if donor BMIs increased or decreased in the years since donation, but obesity at time of donation increased risk of significant physical impairment (PCS) between 5 and 48 years later. The credibility of this finding is supported by a graded relationship: the higher the BMI category, the greater the risk. When BMI and the SF-36 are measured concurrently, worse physical HRQOL (PCS) is consistently reported by the obese and overweight, compared to those in the normal weight range (25, 26) . Bodily pain and mobility are HRQOL, health-related quality of life; MCS, mental component summary; PCS, physical component summary. Data were missing for less than 5% of donors for all variables except educational attainment at donation (missing for 19%); missing values were multiply imputed using the sequential regression imputation method. 1 Significantly impaired physical HRQOL was defined as a PCS >À1 SD below sex-by-age norms (n ¼ 211 out of 2455) 9% of the sample. 2 Significantly impaired mental HRQOL was defined as an MCS >À1 SD below sex-by-age norms (n ¼ 233 of 2455) 9% of the sample. most often negatively affected by obesity. The relationship between weight and mental HRQOL is more nuanced. Longitudinal cohort studies and weight loss trials generally find that gaining weight diminishes physical HRQOL, and losing weight improves both physical and mental HRQOL. Our findings for overweight and obese donors may have important implications for the future HRQOL of all adults who are currently overweight, but otherwise healthy (e.g. have no major comorbidities).
The association of predonation obesity (BMIs > 30) with adverse long-term HRQOL is also notable in light of recent trends to accept heavier donors in the United States. Although the proportion of very obese donors (BMIs > 35) changed little between 1999 and 2009 (from 2% to 3.1%), the proportion of obese donors (BMIs > 30-35) more than doubled (from 8% to 21.8%) during this interval (3). Increased follow-up and study of these donors is warranted. Our findings also add support to current practices of excluding very obese donors, given higher surgical complication rates, the natural history of metabolic syndrome and recent evidence of poor long-term medical outcomes (14) . Nogueira et al (14) found 42% of obese kidney donors (N ¼ 36, average 7 years postdonation) were hypertensive and 47% had compromised renal function.
Donor experience of long recovery time, complications and low donor support and attention were associated with impaired function and well-being many years after donation. These associations suggest that initiatives to improve the donor experience should be seriously considered.
In the past, it has been difficult to identify robust predictors of poor HRQOL among donors (5), and center differences, small sample sizes and limited follow-up have been identified as contributing to this problem. Varying definitions of HRQOL may also contribute, as we found differences in the predonation factors that predicted physical versus mental HRQOL impairment. Notably, obesity and non-White race were risk factors specifically for impaired physical HRQOL and older age at donation was specifically associated with reduced risk of impaired mental HRQOL. Donor history of psychiatric difficulties (donor chart documentation of history or treatment for depression, anxiety, posttraumatic stress disorder or other disorders), which has been regularly identified as a risk factor for poor outcomes (5, 27, 28) , was a risk factor for both poor physical and mental HRQOL in our sample.
The main strength of RELIVE is its size, multi-center collaboration and length of follow-up. Limitations include the absence of predonation HRQOL data, and substantial under-representation of minority donors. Although 9.6% of donors in our study eligibility window were AfricanAmerican, proportionately fewer African-Americans than White donors responded to study contacts, and as a result, African-Americans comprised only 5% of the RELIVE donor sample. Fewer than 2% of the donors in our eligibility window were Hispanic or Latino, and these donors were also less likely than White donors to respond to study contacts. In retrospect, greater efforts should have been made to devise more effective approaches for contacting minority donors. Overall, only 50% of the donors whose surgeries were identified from medical records responded to study contact attempts. No current contact information was available for over 900 donors, despite use of a feebased Internet search service to locate current addresses and phone numbers. These limitations reflect the ambitious nature of securing follow-up as long as 50 years after donation. Finally, it should be kept in mind that RELIVE donors are from three centers, and are not a representative national sample.
A number of factors, in addition to race, differed between donors who did and did not participate in RELIVE, including age, education, time from donation and relationship to the recipient. Because our primary HRQOL results were ageadjusted and effects of all these factors were estimated in multivariate analyses, we do not believe that these factors served to bias our findings.
In conclusion, the majority of living kidney donors maintain average or above average HRQOL over the long term. Findings suggest potential donors who are overweight or obese, less educated, have prior psychiatric difficulties, are not White, or not first-degree relatives of the recipient represent groups at risk for poor HRQOL. New or enhanced efforts of predonation counseling and education, particularly weight loss counseling, and postdonation monitoring efforts could improve outcomes of these donors.
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